Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Sending Out an SOS: How Telomeres Incriminate Cells That Can't Divide

13.03.2012
Salk scientists' discovery explains how a class of chemotherapy drugs works
The well-being of living cells requires specialized squads of proteins that maintain order. Degraders chew up worn-out proteins, recyclers wrap up damaged organelles, and-most importantly-DNA repair crews restitch anything that resembles a broken chromosome. If repair is impossible, the crew foreman calls in executioners to annihilate a cell. As unsavory as this last bunch sounds, failure to summon them is one aspect of what makes a cancer cell a cancer cell.

A recent study from scientists at Salk Institute for Biological Studies showed exactly how cells sense the possibility that their DNA is damaged as a first step to responding to the failure to divide properly. That study, published March 11 in Nature Structural and Molecular Biology, found that if cells take too long to undergo cell division, structures at the tips of their chromosomes, known as telomeres, send out a molecular SOS signal.

These findings have dual implications for cancer chemotherapy. First, they show how a class of anti-cancer drugs that slows cell division ---- known as mitotic inhibitors---- kills cells.This class includes the common chemotherapy drugs Vinblastine, Taxol and Velcade. More significantly, the findings suggest ways to make therapy with those inhibitors more potent.

"How mitotic inhibitors work as cancer therapy has been a 25-year-old question," says Jan Karlseder, a professor in Salk's Molecular and Cell Biology Laboratory and the study's senior author. "These drugs are widely used, but it was unclear why they actually kill cancer cells."

The Karlseder lab has long been fascinated by the roles played by telomeres in aging and cancer. Often described as the genomic equivalent of the plastic caps that keep shoelaces from fraying, telomeres form a protective protein/DNA cap on each end of linear chromosomes, masking those ends from vigilant but apparently myopic repair proteins, who might mistake exposed chromosome ends for broken DNA.

Initially, the group searched for specific proteins that might keep telomeres intact during cell division. To do so, they genetically eliminated candidate proteins one by one and then examined cells using fluorescence microscopy to detect whether telomeres became damaged. What they found was unexpected ---- namely, that any manipulation that crippled and prolonged cell division produced increased numbers of punctate telomere blobs indicative of "unprotected" telomeres.

Treating cells with mitotic inhibitors used in cancer chemotherapy did the very same thing. Those studies established a link between arrested mitosis, telomere perturbation and cell death.
They then confirmed that as cells stalled in mitosis, telomeric shoelace caps started to disintegrate. "Normally the ends of chromosomes are covered by the protein TRF2, which protects the telomere," says Makoto Hayashi, a postdoctoral fellow in the Karlseder lab and the study's first author. "But we found that, during mitotic arrest TRF2 dissociates from telomeres, exposing chromosome ends as damaged DNA. That likely activates a DNA damage signal."

The clincher came when the investigators found that the longer cells endured telomere distress, the more massively they induced what ought to be everyone's most treasured gene, the tumor suppressor p53.

"DNA damage signals occurring during mitotic arrest likely predispose cells to upregulate p53 in the following phase," says Hayashi. "This then either halts the cell cycle to enable DNA repair to occur or commits cells to a suicide pathway called 'apoptosis'."

Karlseder notes that p53 and proteins it mobilizes constitute the most frequently mutated pathway in cancer. "A functional p53 pathway is a healthy sign, as it is the cell's first responder to DNA breaks or telomere dysfunction," he says, "Without it, chromosomes could become unstable and could fuse to one another or break, leading to a loss of genome integrity and uncontrolled growth."

This work suggests novel strategies that could be used in combinatorial cancer chemotherapy regimes, which rely on the synergy between two or more drugs. The theory is that a multi-pronged approach might pack more of a wallop than a sledgehammer alone, as evidenced by the highly effective "triple cocktail" of drugs now used to treat AIDS.

"To make therapy more effective and reduce side effects, we might be able to use more moderate levels of mitotic inhibitors, which at high doses can cause severe side effects, paired with a different drug that sensitizes cells to the DNA damage response," says Karlseder. "That could improve the chances of catching 100 percent of the tumor cells."

Prior to this study telomeres were already celebrated for the fact that they regulate aging by acting as a cellular clock, which ticks down a cell's age. "Every time a cell divides, a little bit of the telomere cap is lost until it is gone, signaling that cells cannot divide anymore," explains Karlseder. "This limitation ensures that cells do not become immortal or cancerous."

Recent studies show, however, that among their other insidious activities, cancer cells figure out how to set back the telomere clock and keep them immortal. "They do this by switching on pathways that specifically lengthen telomeres," says Karlseder. "These pathways therefore represent an important potential target for therapy."

Also contributing to this study were Anthony Cesare, of the Karlseder Lab; James Fitzpatrick, director of Salk's Waitt Advanced Biophotonics Core Facility; and Eros Lazzerini-Denchi, of The Scripps Research Institute in La Jolla.

Funding for the study came from the National Institutes of Health, the Human Frontier Science Program and the Japan Society for the Promotion of Science.

About the Salk Institute for Biological Studies:
The Salk Institute for Biological Studies is one of the world's preeminent basic research institutions, where internationally renowned faculty probe fundamental life science questions in a unique, collaborative, and creative environment. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer's, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology, and related disciplines.

Image: Courtesy of Jan Karlseder, Professor, Molecular and Cellular Biology Laboratory, Makoto Hayashi, research associate and James Fitzpatrick, Waitt Advanced Biophotonics Center

This microscope image shows chromosomes in human lung cells exhibiting telomere damage caused by colcemid, a drug that arrests cell division. The Salk scientists discovered the molecular pathway that initiates a stress response upon treatment with chemotherapy drugs, resulting in a cessation of cell growth or cell death.

Faculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, M.D., the Institute is an independent nonprofit organization and architectural landmark.

Andy Hoang | Newswise Science News
Further information:
http://www.salk.edu

More articles from Life Sciences:

nachricht Toward a 'smart' patch that automatically delivers insulin when needed
18.01.2017 | American Chemical Society

nachricht 127 at one blow...
18.01.2017 | Stiftung Zoologisches Forschungsmuseum Alexander Koenig, Leibniz-Institut für Biodiversität der Tiere

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

A big nano boost for solar cells

18.01.2017 | Power and Electrical Engineering

Glass's off-kilter harmonies

18.01.2017 | Materials Sciences

Toward a 'smart' patch that automatically delivers insulin when needed

18.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>